We encourage all customers to consult with their healthcare provider to determine the best treatment options for their specific health needs.
Section 503A permits compounding of drug products as customized therapies for identified individual patients whose medical needs cannot be met by commercially available drug products. 503B compounding , on the other hand, is performed at outsourcing facilities, which are subject to stricter FDA oversight, including cGMP requirements, a requirement to register with FDA, periodic FDA inspections and an obligation to submit adverse event reports and other product-specific information to FDA
You draw from the vial with a syringe
After practicing family medicine for 15 years, Christina transitioned to a full-time obesity medicine practice in 2023
The synergy isn't additiveit's multiplicative, provided dosing timing prevents competitive inhibition at the cellular level
Underlying biology in MCS: Lets dive into more of the research on what is going on in the body with MCS